Zai Lab (ZLAB) Stock Forecast, Price Target & Predictions
ZLAB Stock Forecast
Zai Lab stock forecast is as follows: an average price target of $101.00 (represents a 392.44% upside from ZLAB’s last price of $20.51) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.
ZLAB Price Target
The average price target for Zai Lab (ZLAB) is $101.00 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $101.00 to $101.00. This represents a potential 392.44% upside from ZLAB's last price of $20.51.
ZLAB Analyst Ratings
According to 2 Wall Street analysts, Zai Lab's rating consensus is 'Buy'. The analyst rating breakdown for ZLAB stock is 0 'Strong Buy' (0.00%), 2 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Zai Lab Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Apr 21, 2022 | - | Leerink Partners | $101.00 | $42.88 | 135.54% | 392.44% |
The latest Zai Lab stock forecast, released on Apr 21, 2022 by Leerink Partners company, set a price target of $101.00, which represents a 135.54% increase from the stock price at the time of the forecast ($42.88), and a 392.44% increase from ZLAB last price ($20.51).
Zai Lab Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | - |
| Avg Price Target | - | - | - |
| Last Closing Price | $20.51 | $20.51 | $20.51 |
| Upside/Downside | -100.00% | -100.00% | -100.00% |
In the current month, the average price target of Zai Lab stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Zai Lab's last price of $20.51. This month's average price target is down NaN% compared to last quarter, and down NaN% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Apr 09, 2024 | Bank of America Securities | Buy | Buy | Hold |
| Oct 26, 2023 | Goldman Sachs | Buy | Buy | Hold |
Zai Lab's last stock rating was published by Bank of America Securities on Apr 09, 2024. The company gave ZLAB a "Buy" rating, the same as its previous rate.
Zai Lab Financial Forecast
Zai Lab Revenue Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | $69.23M | $68.86M | $62.80M | $62.60M | $57.54M | - | $46.72M | $44.17M | $43.10M | $36.94M | $20.10M | $15.09M | $14.65M | $10.99M | $8.22M | $4.65M |
| Avg Forecast | $151.10M | $138.50M | $127.70M | $118.50M | $110.48M | $104.55M | $93.16M | $75.24M | $72.14M | $66.41M | $70.48M | $65.12M | $62.79M | $53.75M | $47.13M | $44.58M | $47.89M | $43.77M | $27.41M | $17.66M | $25.45M | $15.83M | $-1.64M | $36.00K | $10.00M |
| High Forecast | $159.05M | $145.79M | $134.42M | $124.73M | $116.29M | $108.28M | $98.06M | $79.20M | $76.07M | $69.90M | $74.19M | $68.55M | $66.09M | $56.57M | $47.13M | $45.03M | $48.38M | $44.22M | $27.69M | $17.84M | $25.71M | $16.00M | $-1.61M | $36.37K | $10.10M |
| Low Forecast | $140.32M | $128.62M | $118.59M | $110.05M | $102.59M | $102.00M | $86.52M | $69.87M | $67.70M | $61.67M | $65.45M | $60.48M | $58.31M | $49.91M | $47.13M | $43.73M | $46.98M | $42.94M | $26.88M | $17.32M | $24.96M | $15.53M | $-1.65M | $35.31K | $9.81M |
| # Analysts | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 4 | 5 | 4 | 4 | 4 | 3 | 3 | 1 | - | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | - |
| Surprise % | - | - | - | - | - | - | - | - | - | 1.04% | 0.98% | 0.96% | 1.00% | 1.07% | - | 1.05% | 0.92% | 0.98% | 1.35% | 1.14% | 0.59% | 0.93% | -6.71% | 228.28% | 0.46% |
Zai Lab's average Quarter revenue forecast for Dec 23 based on 5 analysts is $72.14M, with a low forecast of $67.70M, and a high forecast of $76.07M. ZLAB's average Quarter revenue forecast represents a 4.21% increase compared to the company's last Quarter revenue of $69.23M (Sep 23).
Zai Lab EBITDA Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 4 | 5 | 4 | 4 | 4 | 3 | 3 | 1 | - | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | - |
| EBITDA | - | - | - | - | - | - | - | - | - | $-83.57M | $-89.50M | $-78.43M | $-136.00M | $-126.36M | - | $-77.75M | $-209.95M | $-94.78M | $-161.80M | $-231.46M | $-75.14M | $-62.55M | $-79.54M | $-46.86M | $-45.14M |
| Avg Forecast | $-151.10M | $-138.50M | $-127.70M | $-118.50M | $-110.48M | $-104.55M | $-93.16M | $-75.24M | $-72.14M | $-66.41M | $-70.48M | $-65.12M | $-62.79M | $-123.59M | $-47.13M | $-44.58M | $-47.89M | $-112.35M | $-139.88M | $-178.77M | $-25.45M | $-15.83M | $1.64M | $-36.00K | $-18.13M |
| High Forecast | $-140.32M | $-128.62M | $-118.59M | $-110.05M | $-102.59M | $-102.00M | $-86.52M | $-69.87M | $-67.70M | $-61.67M | $-65.45M | $-60.48M | $-58.31M | $-98.87M | $-47.13M | $-43.73M | $-46.98M | $-89.88M | $-111.90M | $-143.01M | $-24.96M | $-15.53M | $1.65M | $-35.31K | $-14.50M |
| Low Forecast | $-159.05M | $-145.79M | $-134.42M | $-124.73M | $-116.29M | $-108.28M | $-98.06M | $-79.20M | $-76.07M | $-69.90M | $-74.19M | $-68.55M | $-66.09M | $-148.31M | $-47.13M | $-45.03M | $-48.38M | $-134.83M | $-167.85M | $-214.52M | $-25.71M | $-16.00M | $1.61M | $-36.37K | $-21.75M |
| Surprise % | - | - | - | - | - | - | - | - | - | 1.26% | 1.27% | 1.20% | 2.17% | 1.02% | - | 1.74% | 4.38% | 0.84% | 1.16% | 1.29% | 2.95% | 3.95% | -48.56% | 1301.64% | 2.49% |
undefined analysts predict ZLAB's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Zai Lab's previous annual EBITDA (undefined) of $NaN.
Zai Lab Net Income Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 4 | 5 | 4 | 4 | 4 | 3 | 3 | 1 | - | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | - |
| Net Income | - | - | - | - | - | - | - | - | - | $-69.15M | $-120.89M | $-28.77M | $-26.25M | $-158.96M | - | $-84.80M | $-203.94M | $-109.28M | $-155.67M | $-238.92M | $-57.39M | $-50.96M | $-77.02M | $-49.52M | $-40.56M |
| Avg Forecast | $-47.82M | $-51.72M | $-53.68M | $-53.68M | $-76.35M | $-74.33M | $-69.13M | $-90.26M | $-83.52M | $-101.90M | $-77.14M | $-92.53M | $-108.25M | $-125.72M | $-104.68M | $-122.21M | $-129.34M | $-114.29M | $-141.20M | $-179.89M | $-164.37M | $-164.37M | $-57.73M | $-61.03M | $-18.65M |
| High Forecast | $-43.39M | $-46.93M | $-48.70M | $-48.70M | $-69.27M | $-61.94M | $-62.72M | $-81.89M | $-74.88M | $-92.45M | $-69.98M | $-83.95M | $-98.21M | $-100.58M | $-104.68M | $-119.18M | $-126.14M | $-91.44M | $-112.96M | $-143.91M | $-160.29M | $-160.29M | $-56.30M | $-59.52M | $-14.92M |
| Low Forecast | $-51.09M | $-55.26M | $-57.35M | $-57.35M | $-81.57M | $-84.65M | $-73.86M | $-96.44M | $-93.12M | $-108.86M | $-82.41M | $-98.86M | $-115.66M | $-150.87M | $-104.68M | $-123.83M | $-131.06M | $-137.15M | $-169.44M | $-215.86M | $-166.56M | $-166.56M | $-58.50M | $-61.84M | $-22.37M |
| Surprise % | - | - | - | - | - | - | - | - | - | 0.68% | 1.57% | 0.31% | 0.24% | 1.26% | - | 0.69% | 1.58% | 0.96% | 1.10% | 1.33% | 0.35% | 0.31% | 1.33% | 0.81% | 2.18% |
Zai Lab's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. ZLAB's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
Zai Lab SG&A Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 4 | 5 | 4 | 4 | 4 | 3 | 3 | 1 | - | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | - |
| SG&A | - | - | - | - | - | - | - | - | - | $68.55M | $67.92M | $62.51M | $72.02M | $66.56M | - | $56.99M | $69.58M | $59.00M | $54.41M | $35.84M | $40.97M | $27.87M | $23.76M | $18.71M | $23.02M |
| Avg Forecast | $346.24M | $317.37M | $292.62M | $271.54M | $253.15M | $239.57M | $213.48M | $8.42M | $165.31M | $152.17M | $161.50M | $9.00M | $143.88M | $123.16M | $107.98M | $9.63M | $109.75M | $100.31M | $62.80M | $40.46M | $58.32M | $36.28M | $-3.75M | $82.49K | $9.25M |
| High Forecast | $364.45M | $334.06M | $308.01M | $285.82M | $266.47M | $248.11M | $224.71M | $10.10M | $174.32M | $160.18M | $170.00M | $10.80M | $151.45M | $129.64M | $107.98M | $11.55M | $110.87M | $101.33M | $63.44M | $40.88M | $58.91M | $36.65M | $-3.68M | $83.33K | $11.10M |
| Low Forecast | $321.54M | $294.72M | $271.74M | $252.16M | $235.09M | $233.72M | $198.25M | $6.73M | $155.14M | $141.32M | $149.98M | $7.20M | $133.61M | $114.37M | $107.98M | $7.70M | $107.65M | $98.39M | $61.60M | $39.69M | $57.20M | $35.59M | $-3.79M | $80.92K | $7.40M |
| Surprise % | - | - | - | - | - | - | - | - | - | 0.45% | 0.42% | 6.95% | 0.50% | 0.54% | - | 5.92% | 0.63% | 0.59% | 0.87% | 0.89% | 0.70% | 0.77% | -6.33% | 226.86% | 2.49% |
Zai Lab's average Quarter SG&A projection for Dec 23 is $165.31M, based on 5 Wall Street analysts, with a range of $155.14M to $174.32M. The forecast indicates a 141.14% rise compared to ZLAB last annual SG&A of $68.55M (Sep 23).
Zai Lab EPS Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 4 | 5 | 4 | 4 | 4 | 3 | 3 | 1 | - | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | - |
| EPS | - | - | - | - | - | - | - | - | - | $-0.71 | $-0.00 | $-0.30 | $-0.27 | $-1.66 | - | $-0.89 | $-2.15 | $-1.15 | $-1.67 | $-2.70 | $-0.65 | $-0.68 | $-1.03 | $-0.68 | $-0.56 |
| Avg Forecast | $-0.49 | $-0.53 | $-0.55 | $-0.55 | $-0.78 | $-0.76 | $-0.71 | $-0.92 | $-0.86 | $-1.04 | $-0.79 | $-0.95 | $-1.11 | $-1.25 | $-1.08 | $-1.26 | $-1.33 | $-1.18 | $-1.06 | $-1.58 | $-1.70 | $-1.70 | $-0.60 | $-0.63 | $-0.94 |
| High Forecast | $-0.44 | $-0.48 | $-0.50 | $-0.50 | $-0.71 | $-0.63 | $-0.64 | $-0.84 | $-0.77 | $-0.95 | $-0.72 | $-0.86 | $-1.01 | $-1.13 | $-1.08 | $-1.23 | $-1.30 | $-1.15 | $-1.04 | $-1.54 | $-1.65 | $-1.65 | $-0.58 | $-0.61 | $-0.92 |
| Low Forecast | $-0.52 | $-0.57 | $-0.59 | $-0.59 | $-0.84 | $-0.87 | $-0.76 | $-0.99 | $-0.95 | $-1.12 | $-0.84 | $-1.01 | $-1.19 | $-1.33 | $-1.08 | $-1.28 | $-1.35 | $-1.19 | $-1.08 | $-1.60 | $-1.72 | $-1.72 | $-0.60 | $-0.64 | $-0.95 |
| Surprise % | - | - | - | - | - | - | - | - | - | 0.68% | 0.00% | 0.32% | 0.24% | 1.33% | - | 0.71% | 1.61% | 0.98% | 1.57% | 1.71% | 0.38% | 0.40% | 1.73% | 1.08% | 0.60% |
According to undefined Wall Street analysts, Zai Lab's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to ZLAB previous annual EPS of $NaN (undefined).
Zai Lab Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| ZLAB | Zai Lab | $20.51 | $101.00 | 392.44% | Buy |
| ERAS | Erasca | $2.97 | $7.00 | 135.69% | Buy |
| APLS | Apellis Pharmaceuticals | $37.62 | $75.81 | 101.52% | Buy |
| CGEM | Cullinan Oncology | $17.95 | $32.00 | 78.27% | Buy |
| CCCC | C4 Therapeutics | $6.44 | $11.33 | 75.93% | Hold |
| AKRO | Akero Therapeutics | $27.34 | $43.50 | 59.11% | Buy |
| LEGN | Legend Biotech | $50.31 | $78.78 | 56.59% | Buy |
| ASND | Ascendis Pharma | $119.22 | $174.46 | 46.33% | Buy |
| MDGL | Madrigal Pharmaceuticals | $241.80 | $315.75 | 30.58% | Buy |
| PTCT | PTC Therapeutics | $33.99 | $44.33 | 30.42% | Hold |
| ROIV | Roivant Sciences | $11.94 | $15.36 | 28.64% | Buy |
| BPMC | Blueprint Medicines | $88.90 | $101.50 | 14.17% | Buy |
| KRYS | Krystal Biotech | $201.58 | $191.00 | -5.25% | Buy |
| ALNY | Alnylam Pharmaceuticals | $265.27 | $250.16 | -5.70% | Buy |
| RXDX | Prometheus Biosciences | $199.92 | $138.57 | -30.69% | Buy |
ZLAB Forecast FAQ
Is Zai Lab a good buy?
Yes, according to 2 Wall Street analysts, Zai Lab (ZLAB) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 100.00% of ZLAB's total ratings.
What is ZLAB's price target?
Zai Lab (ZLAB) average price target is $101 with a range of $101 to $101, implying a 392.44% from its last price of $20.51. The data is based on 2 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Zai Lab stock go up soon?
According to Wall Street analysts' prediction for ZLAB stock, the company can go up by 392.44% (from the last price of $20.51 to the average price target of $101), up by 392.44% based on the highest stock price target, and up by 392.44% based on the lowest stock price target.
Can Zai Lab stock reach $30?
ZLAB's average twelve months analyst stock price target of $101 supports the claim that Zai Lab can reach $30 in the near future.
What are Zai Lab's analysts' financial forecasts?
Zai Lab's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $383.43M (high $401.82M, low $360.98M), average EBITDA is $-383M (high $-361M, low $-402M), average net income is $-310M (high $-276M, low $-337M), average SG&A $714.62M (high $749.39M, low $673.79M), and average EPS is $-3.177 (high $-2.826, low $-3.448). ZLAB's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $535.8M (high $563.98M, low $497.57M), average EBITDA is $-536M (high $-498M, low $-564M), average net income is $-207M (high $-188M, low $-221M), average SG&A $1.23B (high $1.29B, low $1.14B), and average EPS is $-2.12 (high $-1.923, low $-2.265).
Did the ZLAB's actual financial results beat the analysts' financial forecasts?
Based on Zai Lab's last annual report (Dec 2023), the company's revenue was $266.72M, which missed the average analysts forecast of $274.15M by -2.71%. Apple's EBITDA was $-367M, beating the average prediction of $-274M by 33.71%. The company's net income was $-335M, missing the average estimation of $-355M by -5.76%. Apple's SG&A was $281.61M, missing the average forecast of $487.99M by -42.29%. Lastly, the company's EPS was $-34.63, beating the average prediction of $-3.638 by 851.80%. In terms of the last quarterly report (Sep 2023), Zai Lab's revenue was $69.23M, beating the average analysts' forecast of $66.41M by 4.24%. The company's EBITDA was $-83.57M, beating the average prediction of $-66.41M by 25.84%. Zai Lab's net income was $-69.152M, missing the average estimation of $-102M by -32.14%. The company's SG&A was $68.55M, missing the average forecast of $152.17M by -54.95%. Lastly, the company's EPS was $-0.71, missing the average prediction of $-1.044 by -32.00%